Lecirelin

Lecirelin, or lecirelin acetate, sold under the brand names Dalmarelin, Ovucron, and Reproreline, is a short-acting gonadotropin-releasing hormone agonist (GnRH agonist) medication which is used in veterinary medicine in Europe and Israel.[1][2][3][4] It is a GnRH analogue and a synthetic peptide, specifically a nonapeptide.[1][2][3] The drug was introduced for veterinary use by 2000.[5]

Lecirelin
Clinical data
Trade namesDalmarelin, Ovucron, Reproreline
Other namesH-Pyr-His-Trp-Ser-Tyr-D-Gly(tBu)-Leu-Arg-Pro-NHEt; XHWSYXLRP
Routes of
administration
Injection
Drug classGnRH agonist
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC59H84N16O12
Molar mass1209.421 g·mol−1
3D model (JSmol)

See also

References

  1. https://www.drugs.com/international/lecirelin.html
  2. Farkas E, Ryadnov M (31 August 2013). Amino Acids, Peptide and Proteins. Royal Society of Chemistry. pp. 226–227. ISBN 978-1-84973-585-8.
  3. Löscher W, Richter A, Potschka H (3 September 2014). Pharmakotherapie bei Haus- und Nutztieren: Begründet von W. Löscher, F.R. Ungemach und R. Kroker. Enke. pp. 435–. ISBN 978-3-8304-1251-9.
  4. Speer B (21 December 2015). Current Therapy in Avian Medicine and Surgery - E-Book. Elsevier Health Sciences. pp. 448–. ISBN 978-0-323-24367-4.
  5. http://agris.fao.org/agris-search/search.do?recordID=PK2007001238



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.